Financhill
Sell
30

IBRX Quote, Financials, Valuation and Earnings

Last price:
$2.37
Seasonality move :
74.15%
Day range:
$2.24 - $2.32
52-week range:
$1.83 - $5.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.73x
P/B ratio:
--
Volume:
6.8M
Avg. volume:
10.2M
1-year change:
-49.89%
Market cap:
$2.3B
Revenue:
$14.7M
EPS (TTM):
-$0.42

Earnings Data

Next earnings date for IBRX
Mar 02
2026
Most recent earnings per share
-$0.07
Beat by $0.03
(Nov 10/2025)
Consensus Estimate
-$0.10
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IBRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/02/2026 Q4 $36M -- -- -$0.10 --
11/10/2025 Q3 $31.9M $32.1M -$0.07 -$0.10 $0.03
07/25/2025 Q2 $24.1M $26.4M -$0.10 -$0.10 -$0.00
05/08/2025 Q1 $16.6M $16.5M -$0.15 -$0.14 -$0.01
03/03/2025 Q4 $9.5M $7.6M -$0.09 -$0.13 $0.04
11/12/2024 Q3 $2.9M $6.1M -$0.14 -$0.18 $0.04
08/12/2024 Q2 $2.5M $1M -$0.20 -- --
05/09/2024 Q1 $25K $40K -$0.20 -- --
12/31/2023 Q4 $25K $139K -$0.38 -- --
11/09/2023 Q3 -- -- -$0.19 -- --
08/08/2023 Q2 -- -- -$0.32 -- --
05/11/2023 Q1 -- -- -$0.27 -- --
12/31/2022 Q4 -- -- -$0.27 -- --
11/09/2022 Q3 -- -- -$0.28 -- --
08/08/2022 Q2 -- -- -$0.24 -- --
05/10/2022 Q1 -- -- -$0.26 -- --
12/31/2021 Q4 -- -- -$0.23 -- --
11/12/2021 Q3 -- -- -$0.22 -- --
08/12/2021 Q2 -- -- -$0.23 -- --
05/14/2021 Q1 -- -- -$0.21 -- --
09/30/2020 Q3 -- -- -$0.17 -- --
06/30/2020 Q2 -- -- -$0.13 -- --
03/31/2020 Q1 -- -- -$0.10 -- --

ImmunityBio, Inc. Earnings Questions

  • How Much did ImmunityBio, Inc. Generate in Revenue Last Quarter?

    ImmunityBio, Inc. reported $32.1M worth of top line sales in its most recent quarter.

  • Did ImmunityBio, Inc. Beat Earnings Last Quarter?

    ImmunityBio, Inc. announced earnings per share of -$0.07 which represents a beat of analyst forecast a -$0.10 per share.

  • Is ImmunityBio, Inc. Profitable?

    ImmunityBio, Inc. reported $27.9M that represents $0.03 per share over the last quarter.

  • What is the Analyst Consensus for ImmunityBio, Inc. EPS Next Year?

    ImmunityBio, Inc.'s earnings are forecast to decrease from -$0.62 per share to -$0.67 per share next year representing a decrease of -34.83%.

  • When is ImmunityBio, Inc.'s Earnings Date?

    ImmunityBio, Inc.'s next earnings date is March 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 7.35% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 47.5% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 10.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock